Science Exchange, YC Founder Story

Company: Science Exchange Founders: Elizabeth Iorns (CEO), Dan Knox (COO), Ryan Abbott YC Batch: Summer 2011 (S11) Industry: Life Sciences / B2B Marketplace / R&D Infrastructure Founded: May 2011 | Public Launch: August 2011 Total Raised: $60+ Million Outcome: Acquired by Waud Capital Partners, late 2024 Investors: Andreessen Horowitz, Union Square Ventures, Index Ventures, Sam Altman, Steve Case, Paul Buchheit, YC Continuity Fund

---

---

The One-Line Summary

A breast cancer researcher in Miami couldn't find a lab to run a single experiment for her, so she built the platform that eventually became the Amazon of scientific R&D, trusted by 8 of the world's top 10 pharmaceutical companies.

---

Lens 1, The Before State

Who Was Elizabeth Iorns Before YC?

Elizabeth Iorns was not a founder. She was not a builder. She did not have a startup background, a CS degree, or a single line of code to her name.

She was an Assistant Professor at the University of Miami Miller School of Medicine, running a research lab focused on understanding how breast cancer develops and spreads. She had a PhD in Cancer Biology from the Institute of Cancer Research in London. She was, by every definition, exactly the kind of person who was not supposed to start a YC company.

Her life followed the rigidly structured path of academic science: write grant proposals to fund experiments, run those experiments, publish the results, apply for the next grant, repeat. The career ladder in academia is long, narrow, and unforgiving, and she was climbing it correctly.

Born in New Zealand, educated in the UK, now running a lab in Miami, Elizabeth was thousands of miles from Silicon Valley in every sense of the phrase.

The Personal Pain She Was Living

It started with one experiment she couldn't run herself.

Elizabeth needed to conduct immunology experiments, work that was outside the specific technical expertise of her own lab. The standard process was: Google the right keywords, manually email dozens of different labs, wait for replies, negotiate pricing back-and-forth, evaluate quality without any real metrics or reviews, finally negotiate a contract that would take months to execute.

She described it later: "I had to google the right keywords, email dozens of different labs, figure out pricing and turnaround times, all the while trying to evaluate quality metrics in the absence of user feedback or reviews."

This was the state of scientific outsourcing in 2011. Not some obscure edge case, this was how every researcher at every institution in the world sourced outside expertise. There was no platform. No marketplace. No ratings. No standardised contracts. Just email, waiting, and bureaucratic friction at every step.

The irony was brutal: the people trying to cure diseases and advance human knowledge were spending enormous chunks of their time navigating procurement paperwork instead of doing science.

Why She Almost Didn't Apply

Elizabeth carried the most crippling form of self-doubt a founder can have: the belief that because she came from academia and not technology, she had no business building a tech company.

She had no software background. She had never raised venture capital. She didn't know what a cap table was. The YC application form, with its questions about growth metrics, monetisation strategies, and technical architecture, was written in a language she hadn't learned.

Worse, the conventional wisdom in her world was clear: professors build careers in academia. The idea of abandoning tenure track, one of the most coveted, hard-earned positions in all of science, to start a startup would have seemed reckless to most of her peers.

She co-founded Science Exchange in May 2011 and applied to YC's Summer batch just weeks later. The decision to apply was itself an act of courage.

Key Insight for Aspiring Founders

You don't need to be a technologist to start a tech company. You need to understand your user's pain better than any technologist ever could. Elizabeth Iorns knew the exact frustration of every researcher on the planet because she had lived it, measured it, and felt the daily cost of it. That domain depth is worth more than any coding bootcamp.

---

Lens 2, The Idea Origin

How the Idea Was Actually Born

The idea was born out of a conversation, not a brainstorming session, not a hackathon, not a business school exercise.

Elizabeth was talking about her research frustrations with her co-founder Dan Knox, an economist. What she described as a logistical annoyance, Dan immediately recognised as a classic marketplace problem: a fragmented, opaque market with high search costs, no price transparency, and no quality signals. The kind of market that a well-designed platform could completely transform.

The pairing was perfect in retrospect: Elizabeth had the domain expertise and the lived pain; Dan had the economic framework to understand why the market was broken and how to fix it structurally. Together, they saw what neither could see alone.

Their third co-founder, Ryan Abbott, brought operational skills to build the early product. The founding team covered three distinct domains, science, economics, and operations, without a single professional software engineer among them.

The First Version, A Manual Marketplace

Science Exchange launched in August 2011, just three months after being founded and right at the end of the YC batch. The first version was deliberately simple: a platform where researchers could browse a list of scientific service providers, see what experiments each offered, and request quotes.

There was no algorithmic matching. No automated payments. No integrated contract management. What the platform did was radically reduce the search problem, instead of emailing 30 labs blindly, a researcher could see structured listings of providers, their specialties, and what other scientists said about them.

It was the minimum viable version of what they actually wanted to build, and it worked well enough to prove the demand was real.

The first provider to ever appear on the platform? Research facilities that included, remarkably, the ability to run experiments on the International Space Station via a company called Nanoracks. Science Exchange had barely launched and researchers were already discovering capabilities they didn't even know were accessible to them.

The Signal That Validated It

The signal was immediate: researchers found Science Exchange and used it without needing to be convinced it was valuable. The pain it solved was so obvious that the product essentially sold itself in its earliest days. Academics who spent weeks chasing lab collaborations via email could now find, evaluate, and contact providers in an afternoon.

The second, more powerful signal came when pharma companies, not just academic researchers, started knocking. Elizabeth had built the platform for people like herself: lab researchers at universities. But the pharmaceutical industry, spending billions on outsourced R&D every year with the same broken manual processes, saw Science Exchange and immediately understood what it could mean at scale.

The Pattern This Follows

Science Exchange is a textbook example of the "painful unsexy market" YC archetype. The problems worth solving are often in industries that are too boring or too complex for outsiders to bother entering. Scientific procurement is not glamorous. It doesn't make headlines. But the friction was enormous, the market was enormous, and nobody had ever built the right tool because nobody from tech had ever personally felt the pain.

---

Lens 3, The Application Anatomy

What Their YC Application Actually Said

The core of Science Exchange's YC application was later confirmed by the founders themselves. They described their company as:

"An online marketplace for ordering experiments from the world's best labs."